Epidemiological evidence of the link between G6PD & CVD Early epidemiological studies of G6PD-d and atherosclerosis suggested that it may be atheroprotective
ApoB, triglycerides, and the lipid panel Weight loss and GLP-1s both improve your lipid panel, and triglycerides move the most, often dropping 20% or more
Tirzepatides dual-hormone structure and fatty acid modification may add to the challenge of delivering it as a pill
Ready to embark on a transformative journey
Subgroup Analyses All randomised patients in PIONEER 35, 7 and 8 were included in the main background medication subgroup analyses, which were done for each trial separately
Hadidchi will provide expert advice on diet, exercise, and potential adjustments to help you achieve the best possible outcomes from your weight loss journey with Wegovy